To interrogate this correlation between APOE genotype and tau pathology in living individuals, researchers have begun utilizing recently developed tau PET imaging ligands to compare tau levels in APOE4+ vs. APOE4− AD patients. This evidence concerns the gene APOE and Alzheimer disease.